1. Home
  2. /
  3. Acceptability
  4. /
  5. Accelerating research and development of new vaccines against tuberculosis

Accelerating research and development of new vaccines against tuberculosis

Description

Reviews progress since the 2021 Global TB Vaccine R&D Roadmap and identifies remaining actions needed to accelerate availability, access and uptake of new TB vaccines
TB vaccine theme
Acceptability, Accessibility, Availability
Acceptability and demand, Epidemiological impact, Implementation strategies and feasibility, Policy and frameworks

Project details

Country
not specific
Timeline
2021-2025
Target group
Adolescents, Adults
Vaccine
Hypothetical vaccines
Type of protection of vaccine
Prevention of disease
Type of research
Other
Partners involved
; AIGHD, EDCTP, Friedrich-Loeffler-Institut, LSHTM, National Department of Health South Africa, Oregon Health & Science University, Respiratory Programmatic Implementation and Research Institute, SATVI, TBVI, Universitas Indonesia–Persahabatan Hospital, University of Amsterdam, University of the Witwatersrand, WHO
Type of project
research
Funder
EDCTP
Civil Society
Governmental Body
National Department of Health South Africa

Resources

Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap

Contact

Elly van Riet
elly.vanriet@tbvi.eu
Click to copy link of this header Menu